Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Biotech Group Withholds Support for Germline Trial Report

A biotechnology industry association in the U.S. says its members are not ready to support recommendations in a new report permitting future clinical studies of genome editing for inheritable disease-causing traits. . . . → Read More: Biotech Group Withholds Support for Germline Trial Report

FDA Begins Cancer Product Review Center

The U.S. Food and Drug Administration is reorganizing its review of treatments for cancer into a structure that cuts across its traditional bureaucratic lines. . . . → Read More: FDA Begins Cancer Product Review Center

Gene Expression Changes Found in Wound Healing Therapy

A clinical trial to reveal the mechanism of a cell therapy to treat venous skin ulcers found the therapy works by altering the gene expression activity of treated cells to resemble healthy tissue. . . . → Read More: Gene Expression Changes Found in Wound Healing Therapy

Antibody Trials Stopped After Deaths Reported

The U.S. Food and Drug Administration halted early-stage clinical trials of a monoclonal antibody drug for leukemia after four deaths occurred from liver toxicity. . . . → Read More: Antibody Trials Stopped After Deaths Reported

FDA Approves Spinal Muscular Atrophy Drug [Updated]

A drug to treat spinal muscular atrophy, a genetic disorder causing the wasting away of muscle tissue in children and adults, was approved for sale in the U.S. . . . → Read More: FDA Approves Spinal Muscular Atrophy Drug [Updated]

Patent Awarded for Whooping Cough Antibodies

An experimental treatment for pertussis, also known as whooping cough, using engineered humanized antibodies received a patent in the U.S. . . . → Read More: Patent Awarded for Whooping Cough Antibodies

Engineered T-Cell Trial Halted After Participant Dies

A clinical trial testing treatments that modify immune system cells to fight leukemia in adults was stopped after one of the patients died from inflammation in the brain. . . . → Read More: Engineered T-Cell Trial Halted After Participant Dies

Targeted Leukemia Drugs Sharply Raising Costs of Care

Drugs directly attacking cancer cell growth show high remission rates with a common form of leukemia, but a new study suggests the high costs of these drugs could impose difficult economic burdens on patients and the health care system. . . . → Read More: Targeted Leukemia Drugs Sharply Raising Costs of Care

Long-Acting Opioid Abuse Therapy Shown Working in Trial

An experimental long-acting drug was shown at least as effective, and in some cases superior, to the current standard of care for opioid use disorder. . . . → Read More: Long-Acting Opioid Abuse Therapy Shown Working in Trial

Florida Voters Give Split Decision on GM Mosquitoes [Updated]

Voters in the Florida Keys yesterday returned a split decision on non-binding ballot questions about testing genetically modified mosquitoes to stop the Zika virus. . . . → Read More: Florida Voters Give Split Decision on GM Mosquitoes [Updated]